Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:11:46.386Z.
Calculation as of: 2026-10-06T15:11:46.386Z.
Quote observation: 2026-10-06T15:08:40.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dda5353817af794375b978a2faa289dfa66a026ad884c07a98b38d1ad02c68b2
EARNINGS YIELD
N/A
Market Cap
$108.48M
Earnings Yield
N/A
TTM Avg
0.32%
3Y Avg
0.91%
5Y Avg
2.50%
Market Cap
$108.87M
Earnings Yield
N/A
TTM Avg
9.36%
3Y Avg
9.36%
5Y Avg
9.36%
Market Cap
$108.02M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.98M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$109.07M
Earnings Yield
N/A
TTM Avg
26.36%
3Y Avg
26.36%
5Y Avg
26.36%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definitive Healthcare Corp. (DH) | $105.17M | N/A | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $108.48M | N/A | 0.32% | 0.91% | 2.50% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $102.66M | N/A | N/A | N/A | N/A |
| The Joint Corp. (JYNT)vs › | $102.45M | 3.69% | 2.61% | 2.26% | 1.70% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.87M | N/A | 9.36% | 9.36% | 9.36% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.02M | N/A | N/A | N/A | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $108.98M | N/A | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $109.07M | N/A | 26.36% | 26.36% | 26.36% |
| Immunic, Inc. (IMUX)vs › | $108.97M | N/A | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX)vs › | $100.54M | N/A | 0.56% | 0.56% | 0.56% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute